Jeffrey B. Kindler

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
8 years
Director since
2023

8 years of board service in total across 3 boards, counting each seat separately. Longest: Precigen Inc., 3 years.

Precigen Inc. Director
3 years ยท Since 2023
3 years ยท Since 2023
8 months ยท Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 10, 2026 Praxis Precision Medicines Inc. Grant or award +1,371 โ€” โ€”
Mar 13, 2026 Precigen Inc. Option exercise +71,839 โ€” โ€”
Mar 10, 2026 Precigen Inc. Grant or award +19,658 $3.51 $69,000
Feb 6, 2026 Praxis Precision Medicines Inc. Grant or award +688 โ€” โ€”
Feb 6, 2026 Praxis Precision Medicines Inc. Grant or award +478 โ€” โ€”
Dec 12, 2025 Precigen Inc. Open-market sale โˆ’235,467 $3.63 $854,745
Sep 30, 2025 Precigen Inc. Open-market sale โˆ’106,837 $3.38 $361,109
Sep 29, 2025 Precigen Inc. Open-market sale โˆ’67,523 $3.60 $243,083
May 14, 2025 Perrigo Company plc Option exercise +9,904 $26.01 $257,603
May 14, 2025 Perrigo Company plc Shares withheld for tax โˆ’4,754 $26.01 $123,652
Mar 14, 2025 Precigen Inc. Option exercise +87,412 โ€” โ€”
Mar 13, 2025 Precigen Inc. Grant or award +39,655 $1.74 $69,000
Dec 9, 2024 Perrigo Company plc Open-market sale โˆ’17,598 $28.27 $497,495
May 15, 2024 Perrigo Company plc Option exercise +8,764 $30.22 $264,848
May 15, 2024 Perrigo Company plc Shares withheld for tax โˆ’4,207 $30.22 $127,136

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.